Virginia Kaklamani Selected Research

Virginia Kaklamani Research Topics

Disease

24	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2004
19	Neoplasms (Cancer) 01/2022 - 01/2003
5	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2005
3	Disease Progression 01/2019 - 05/2007
3	Carcinogenesis 06/2016 - 12/2007
3	Colorectal Neoplasms (Colorectal Cancer) 05/2010 - 05/2005
2	Triple Negative Breast Neoplasms 01/2021 - 01/2020
2	Insulin Resistance 01/2013 - 09/2011
2	Prostatic Neoplasms (Prostate Cancer) 09/2011 - 09/2004
1	Nausea 01/2021
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2020
1	Pathologic Complete Response 01/2020
1	Ductal Carcinoma 01/2020
1	Weight Loss (Weight Reduction) 08/2017
1	Fatigue 05/2013
1	Stomatitis 05/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2013
1	Malaria 01/2013
1	Liver Diseases (Liver Disease) 01/2013
1	Neutropenia 01/2013
1	Obesity 09/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2010
1	Exanthema (Rash) 08/2010
1	Cardiotoxicity 08/2010
1	Diarrhea 08/2010
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2010
1	Adenocarcinoma 05/2010
1	Colonic Neoplasms (Colon Cancer) 12/2007

Drug/Important Bio-Agent (IBA)

7	Transforming Growth Factor-beta Type I ReceptorIBA 05/2010 - 02/2004
5	Estrogen ReceptorsIBA 01/2022 - 11/2006
5	Transforming Growth Factor beta (TGF-beta)IBA 05/2009 - 01/2003
4	Trastuzumab (Herceptin)FDA Link 12/2021 - 04/2004
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2011
3	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2010
3	ErbB Receptors (EGF Receptor)IBA 12/2021 - 01/2020
2	Estrogens (Estrogen)FDA Link 01/2022 - 06/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2010
2	Everolimus FDA Link 01/2020 - 01/2019
2	AnthracyclinesIBA 05/2019 - 08/2010
2	taxaneIBA 05/2019 - 08/2010
2	Hormones (Hormone)IBA 01/2019 - 08/2010
2	human ERBB2 proteinIBA 05/2013 - 01/2013
2	Sorafenib (BAY 43-9006)FDA Link 05/2013 - 01/2013
2	Capecitabine (Xeloda)FDA Link 05/2013 - 08/2010
2	Bevacizumab (Avastin)FDA Link 05/2013 - 04/2004
2	AdiponectinIBA 01/2013 - 09/2011
1	olaparibIBA 01/2022
1	carbazoleIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	Imipramine (Janimine)FDA LinkGeneric 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 12/2021
1	Ado-Trastuzumab EmtansineIBA 12/2021
1	B7-H1 AntigenIBA 12/2021
1	pertuzumabIBA 12/2021
1	atezolizumabIBA 12/2021
1	Docetaxel (Taxotere)FDA Link 12/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	RAD1901IBA 01/2021
1	elacestrantIBA 01/2021
1	2019-nCoV Vaccine mRNA-1273IBA 01/2021
1	BNT162 VaccineIBA 01/2021
1	mRNA VaccinesIBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	Phosphorus (Red Phosphorus)IBA 01/2021
1	TabletsIBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	PlatinumIBA 01/2020
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2020
1	eribulin FDA Link 05/2019
1	Cytotoxins (Cytolysins)IBA 05/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	Growth Factor ReceptorsIBA 01/2019
1	Estrogen Receptor alphaIBA 06/2016
1	Antipsychotic Agents (Antipsychotics)IBA 06/2014
1	Prolactin Receptors (Prolactin Receptor)IBA 06/2014
1	Gemcitabine FDA Link 05/2013
1	Pemetrexed (MTA)FDA Link 04/2013
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2013
1	Fulvestrant (Faslodex)FDA Link 03/2013
1	C-PeptideIBA 01/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2013
1	Angiogenesis InhibitorsIBA 01/2012
1	Adiponectin ReceptorsIBA 09/2011
1	Letrozole (Femara)FDA LinkGeneric 08/2010
1	Lapatinib (GW572016)FDA Link 08/2010
1	RNA (Ribonucleic Acid)IBA 05/2010
1	Cathepsin DIBA 01/2010
1	EnzymesIBA 01/2010
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2009
1	Aligeron (AS 2)IBA 12/2007

Therapy/Procedure

12	Therapeutics 01/2022 - 04/2004
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2012
2	Immunotherapy 12/2021 - 05/2019
1	Precision Medicine 01/2021
1	Neoadjuvant Therapy 01/2020
1	Drug Tapering 05/2013